WAVE Life Sciences Ltd at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Great. Hey, everyone, thanks for joining us. I'm Marty Auster, one of the SMid-Cap Biotech Analyst here at Crédit Suisse. Thanks for joining us at our 29th Annual Healthcare Conference. I have got Wave Life Sciences' CEO, Paul Bolno, to make a presentation on Wave.
Paul, I'll hand it over to you. Thanks for joining us today. Have a fun presentation.
Marty, thank you so much for having us at the conference today, and we look forward to the opportunity to share more. And with that, before we begin -- there we go. We'll, obviously, be making forward-looking statements during this presentation. So I will refer everyone to our SEC filings for updates. But we're excited to be here. And we're excited to be here because there's a lot going on at Wave as we started out the year and continue on our progress to building a leading-genetic medicines company.
Our foundational work
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |